Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Autoimmune Diseases
Pharma
Roche’s Gazyva wins first FDA nod for membranous nephropathy
Besides lupus nephritis, idiopathic nephrotic syndrome and membranous nephropathy, Gazyva also awaits an FDA decision in systemic lupus erythematosus.
Angus Liu
Nov 16, 2026 11:00am
Cosette lands FDA approval for Evoxac liquid in Sjögren’s
Oct 20, 2026 11:22am
Novartis presses pause on Fabhalta lupus nephritis trial
Oct 19, 2026 10:13am
Novartis' BTK drug clears ph. 3 in MS sans liver safety signal
Sep 1, 2026 11:10am
Argenx preps next potential Vyvgart nod after ph. 3 win
Aug 17, 2026 10:52am
EU regulators offer post-mortem of Tavneos withdrawal decision
Aug 14, 2026 11:04am